skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
07/01/2014
Application #:
12720592
Filing Dt:
03/09/2010
Publication #:
Pub Dt:
09/09/2010
Inventors:
Gary FUJII, Francis C. SZOKA JR., Douglas S. WATSON
Title:
METHODS AND COMPOSITIONS FOR LIPOSOMAL FORMULATION OF ANTIGENS AND USES THEREOF
Assignment: 1
Reel/Frame:
024403/0357Recorded: 05/18/2010Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
03/18/2010
Exec Dt:
03/19/2010
Assignee:
1111 FRANKLIN STREET, 12TH FLOOR
OAKLAND, CALIFORNIA 94607
Correspondent:
MICHAEL A. WHITTAKER
12707 HIGH BLUFF DRIVE, STE. 200
BIOTECHNOLOGY LAW GROUP
SAN DIEGO, CA 92130
Assignment: 2
Reel/Frame:
024403/0315Recorded: 05/18/2010Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
05/05/2010
Assignee:
2011 UNIVERSITY DRIVE
RANCHO DOMINQUEZ, CALIFORNIA 90220
Correspondent:
MICHAEL A. WHITTAKER
12707 HIGH BLUFF DRIVE, STE. 200
BIOTECHNOLOGY LAW GROUP
SAN DIEGO, CA 92130
Assignment: 3
Reel/Frame:
044836/0713Recorded: 12/12/2017Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
12/08/2017
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 04/29/2024 02:36 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT